Role of functional imaging in the management of lymphoma
BD Cheson - Journal of Clinical Oncology, 2011 - ascopubs.org
18-F-fluorodeoxyglucose (FDG)–positron emission tomography (PET), and more recently
PET/computed tomography (CT), is the most sensitive and specific imaging technique …
PET/computed tomography (CT), is the most sensitive and specific imaging technique …
The role of FDG-PET scans in patients with lymphoma
P Seam, ME Juweid, BD Cheson - Blood, The Journal of the …, 2007 - ashpublications.org
Fluoro-deoxyglucose positron emission tomography (FDG-PET) is a noninvasive, 3-
dimensional imaging modality that has become widely used in the management of patients …
dimensional imaging modality that has become widely used in the management of patients …
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification
BD Cheson, RI Fisher, SF Barrington… - Journal of clinical …, 2014 - ascopubs.org
The purpose of this work was to modernize recommendations for evaluation, staging, and
response assessment of patients with Hodgkin lymphoma (HL) and non-Hodgkin lymphoma …
response assessment of patients with Hodgkin lymphoma (HL) and non-Hodgkin lymphoma …
Revised response criteria for malignant lymphoma
BD Cheson, B Pfistner, ME Juweid… - Journal of clinical …, 2007 - ascopubs.org
Purpose Standardized response criteria are needed to interpret and compare clinical trials
and for approval of new therapeutic agents by regulatory agencies. Methods The …
and for approval of new therapeutic agents by regulatory agencies. Methods The …
FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease
The term extranodal disease refers to lymphomatous infiltration of anatomic sites other than
the lymph nodes. Almost any organ can be affected by lymphoma, with the most common …
the lymph nodes. Almost any organ can be affected by lymphoma, with the most common …
Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging
GJR Cook, EA Wegner, I Fogelman - Seminars in nuclear medicine, 2004 - Elsevier
It is estimated that in excess of one million positron emission tomography (PET) scans are
performed each year and PET can now truly be regarded as a routine imaging procedure in …
performed each year and PET can now truly be regarded as a routine imaging procedure in …
PET/CT for therapy response assessment in lymphoma
M Hutchings, SF Barrington - Journal of nuclear medicine, 2009 - Soc Nuclear Med
PET with 18 F-FDG is a standard staging procedure for most lymphoma subtypes. Performed
during and after therapy for Hodgkin lymphoma (HL) and aggressive non-Hodgkin …
during and after therapy for Hodgkin lymphoma (HL) and aggressive non-Hodgkin …
PET/CT for the staging and follow-up of patients with malignancies
TD Poeppel, BJ Krause, TA Heusner, C Boy… - European journal of …, 2009 - Elsevier
Positron emission tomography (PET) and computed tomography (CT) complement each
other's strengths in integrated PET/CT. PET is a highly sensitive modality to depict the whole …
other's strengths in integrated PET/CT. PET is a highly sensitive modality to depict the whole …
A metaanalysis of 18F‐2‐deoxy‐2‐fluoro‐D‐glucose positron emission tomography in the staging and restaging of patients with lymphoma
CR Isasi, P Lu, MD Blaufox - … International Journal of the …, 2005 - Wiley Online Library
BACKGROUND In recent years, the use of positron emission tomography (PET) has become
widespread for the staging and follow‐up of several malignancies. In the current study, the …
widespread for the staging and follow‐up of several malignancies. In the current study, the …
Part II: Hodgkin's lymphoma—diagnosis and treatment
V Diehl, RK Thomas, D Re - The lancet oncology, 2004 - thelancet.com
The outcome of patients with all stages of Hodgkin's lymphoma has improved dramatically
over the past few decades. This is mainly due to the use of risk-adapted therapies using …
over the past few decades. This is mainly due to the use of risk-adapted therapies using …